U.S. Markets open in 3 hrs 50 mins

New Strong Sell Stocks for January 29th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Americas Gold and Silver Corporation USAS is engaged in the acquisition, evaluation, exploration, development, and operation of precious and polymetallic mineral properties. The Zacks Consensus Estimate for its current year earnings has been revised 4.6% downward over the last 30 days.

Caladrius Biosciences, Inc. CLBS is a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 4.6% downward over the last 30 days.

Euronav NV EURN is engaged in the shipping and storage of crude oil. The Zacks Consensus Estimate for its current year earnings has been revised 1.3% downward over the last 30 days.

Tsakos Energy Navigation Limited TNP provides seaborne transportation of crude oil and petroleum products. The Zacks Consensus Estimate for its current year earnings has been revised 2.1% downward over the last 30 days.

Ardmore Shipping Corporation ASC is engaged in the seaborne transportation of petroleum products and chemicals. The Zacks Consensus Estimate for its current year earnings has been revised 50% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Caladrius Biosciences, Inc. (CLBS) : Free Stock Analysis Report
 
Americas Silver Corporation (USAS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research